Literature DB >> 20306467

Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Ming Zhuo1, Masato Fujiki, Mouer Wang, Karine Piard-Ruster, Lu-En Wai, Liang Wei, Olivia M Martinez, Sheri M Krams.   

Abstract

NKG2D is a receptor expressed by NK cells and subsets of T lymphocytes. On NK cells, NKG2D functions as a stimulatory receptor that induces effector functions. We cloned and expressed two rat NKG2D ligands, both members of the RAE1 family, RAE1L and RRLT, and demonstrate that these ligands can induce IFN-gamma secretion and cytotoxicity by rat NK cells. To examine changes in expression of NKG2D and the NKG2D ligands RAE1L and RRLT after transplantation, we used a Dark Agouti (DA)-->Lewis rat model of liver transplantation. NKG2D expression was significantly increased in allogeneic liver grafts by day 7 post-transplant. Ligands of NKG2D, absent in normal liver, were readily detected in both syngeneic and allogeneic liver grafts by day 1 post-transplant. By day 7 post-transplant, hepatocyte RAE1L and RRLT expression was significantly and specifically increased in liver allografts. In contrast to acute rejection that develops in the DA-->Lewis model, transplantation of Lewis livers into DA recipients (Lewis-->DA) results in spontaneous tolerance. Interestingly, expression of RAE1L and RRLT is low in Lewis-->DA liver allografts, but significantly increased in DA-->Lewis liver allografts undergoing rejection. In conclusion, our results suggest that expression of NKG2D ligands may be important in allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306467      PMCID: PMC3057641          DOI: 10.1002/eji.200939779

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

1.  Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.

Authors:  Y Ogura; S M Krams; O M Martinez; S Kopiwoda; J P Higgins; C O Esquivel; H W Strauss; J F Tait; F G Blankenberg
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 2.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

3.  The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection.

Authors:  Jim Kim; Catherine K Chang; Tracy Hayden; Feng-Chun Liu; Jonathan Benjamin; Jessica A Hamerman; Lewis L Lanier; Sang-Mo Kang
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  The JAM test. A simple assay for DNA fragmentation and cell death.

Authors:  P Matzinger
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

5.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Authors:  Robert L Strausberg; Elise A Feingold; Lynette H Grouse; Jeffery G Derge; Richard D Klausner; Francis S Collins; Lukas Wagner; Carolyn M Shenmen; Gregory D Schuler; Stephen F Altschul; Barry Zeeberg; Kenneth H Buetow; Carl F Schaefer; Narayan K Bhat; Ralph F Hopkins; Heather Jordan; Troy Moore; Steve I Max; Jun Wang; Florence Hsieh; Luda Diatchenko; Kate Marusina; Andrew A Farmer; Gerald M Rubin; Ling Hong; Mark Stapleton; M Bento Soares; Maria F Bonaldo; Tom L Casavant; Todd E Scheetz; Michael J Brownstein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Christa Prange; Sam S Raha; Naomi A Loquellano; Garrick J Peters; Rick D Abramson; Sara J Mullahy; Stephanie A Bosak; Paul J McEwan; Kevin J McKernan; Joel A Malek; Preethi H Gunaratne; Stephen Richards; Kim C Worley; Sarah Hale; Angela M Garcia; Laura J Gay; Stephen W Hulyk; Debbie K Villalon; Donna M Muzny; Erica J Sodergren; Xiuhua Lu; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madan; Alice C Young; Yuriy Shevchenko; Gerard G Bouffard; Robert W Blakesley; Jeffrey W Touchman; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Martin I Krzywinski; Ursula Skalska; Duane E Smailus; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Marco A Marra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

6.  Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage.

Authors:  N Kamada; R Y Calne
Journal:  Transplantation       Date:  1979-07       Impact factor: 4.939

7.  Reversal of transplantation immunity by liver grafting.

Authors:  N Kamada; H S Davies; B Roser
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

8.  Apoptosis and allograft rejection in the absence of CD8+ T cells.

Authors:  Y Ogura; O M Martinez; J C Villanueva; J F Tait; H W Strauss; J P Higgins; K Tanaka; C O Esquivel; F G Blankenberg; S M Krams
Journal:  Transplantation       Date:  2001-06-27       Impact factor: 4.939

9.  Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.

Authors:  M W Shelton; L A Walp; J T Basler; K Uchiyama; D W Hanto
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

10.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  12 in total

1.  IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo.

Authors:  Margherita Boieri; Aina Ulvmoen; Amanda Sudworth; Clare Lendrem; Matthew Collin; Anne M Dickinson; Lise Kveberg; Marit Inngjerdingen
Journal:  Oncoimmunology       Date:  2017-01-17       Impact factor: 8.110

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

3.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

4.  Changes in natural killer cell subsets in pediatric liver transplant recipients.

Authors:  Betty Pham; Karine Piard-Ruster; Richard Silva; Amy Gallo; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2012-03

Review 5.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Toll-like receptor 4 contributes to small intestine allograft rejection.

Authors:  Sheri M Krams; Mouer Wang; Ricardo O Castillo; Takashi Ito; Lori Phillips; John Higgins; Neeraja Kambham; Carlos O Esquivel; Olivia M Martinez
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

7.  Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.

Authors:  Lu-En Wai; Jordan A Garcia; Olivia M Martinez; Sheri M Krams
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

8.  Alloimmune activation promotes anti-cancer cytotoxicity after rat liver transplantation.

Authors:  Stéphanie Lacotte; Graziano Oldani; Florence Slits; Lorenzo A Orci; Laura Rubbia-Brandt; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

9.  The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions.

Authors:  Izabela Todros-Dawda; Lise Kveberg; John T Vaage; Marit Inngjerdingen
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

10.  Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice.

Authors:  Li Hua; Mingli Fang; Boqi Dong; Sheng Guo; Cuiyun Cui; Jiwei Liu; Yun Yao; Yue Xiao; Xin Li; Yunjia Ren; Xiuping Meng; Xu Hao; Peiyan Zhao; Yilan Song; Liying Wang; Yongli Yu
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.